Novel mutations in arylsulfatase A gene in three Ukrainian families with metachromatic leukodystrophy. 2003

Natalia V Olkhovich, and Noboru Takamura, and Natalia A Pichkur, and Natalia G Gorovenko, and Kiyoshi Aoyagi, and Shunichi Yamashita
Department of Medical Genetics, Kyiv Medical Academy of Postdiploma Education, Kyiv, Ukraine.

Metachromatic leukodystrophy (MLD) is a lysosomal storage disease caused by the deficiency of arylsulfatase A (ARSA) or saposin B. The majority of mutations identified in patients with MLD are unique within individual families. Here, we report on the novel missense mutations (F247S, D381E, and A469G) and the known mutations "A" allele and P136S in the ARSA gene in three unrelated Ukrainian families with MLD. The mutations F247S and P136S were found in compound heterozygous with the "A" allele in two patients with juvenile onset MLD. The clinical features of the typical patient with genotype D381E/A469G (early onset with very rapid manifestation of disease) suggest the reason to distinguish an early infantile MLD variant.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007966 Leukodystrophy, Metachromatic An autosomal recessive metabolic disease caused by a deficiency of CEREBROSIDE-SULFATASE leading to intralysosomal accumulation of cerebroside sulfate (SULFOGLYCOSPHINGOLIPIDS) in the nervous system and other organs. Pathological features include diffuse demyelination, and metachromatically-staining granules in many cell types such as the GLIAL CELLS. There are several allelic and nonallelic forms with a variety of neurological symptoms. Arylsulfatase A Deficiency Disease,Cerebroside Sulphatase Deficiency Disease,ARSA Deficiency,Arylsulfatase A Deficiency,Cerebral sclerosis, Diffuse, Metachromatic Form,Cerebroside Sulfatase Deficiency,Greenfield Disease,Greenfield's Disease,Leukodystrophy, Metachromatic, Adult,Leukodystrophy, Metachromatic, Juvenile,Metachromatic Leukodystrophy,Metachromatic Leukodystrophy, Adult,Metachromatic Leukodystrophy, Adult-Type,Metachromatic Leukodystrophy, Infant,Metachromatic Leukodystrophy, Infant-Type,Metachromatic Leukodystrophy, Juvenile,Metachromatic Leukodystrophy, Juvenile-Type,Metachromatic Leukodystrophy, Late Infantile,Metachromatic Leukoencephalopathy,Sulfatide Lipidosis,ARSA Deficiencies,Adult Metachromatic Leukodystrophies,Adult Metachromatic Leukodystrophy,Adult-Type Metachromatic Leukodystrophies,Adult-Type Metachromatic Leukodystrophy,Arylsulfatase A Deficiencies,Cerebroside Sulfatase Deficiencies,Deficiencies, ARSA,Deficiencies, Arylsulfatase A,Deficiencies, Cerebroside Sulfatase,Deficiency, ARSA,Deficiency, Arylsulfatase A,Deficiency, Cerebroside Sulfatase,Infant Metachromatic Leukodystrophies,Infant Metachromatic Leukodystrophy,Infant-Type Metachromatic Leukodystrophies,Infant-Type Metachromatic Leukodystrophy,Juvenile Metachromatic Leukodystrophies,Juvenile Metachromatic Leukodystrophy,Juvenile-Type Metachromatic Leukodystrophies,Juvenile-Type Metachromatic Leukodystrophy,Leukodystrophies, Adult Metachromatic,Leukodystrophies, Adult-Type Metachromatic,Leukodystrophies, Juvenile Metachromatic,Leukodystrophies, Juvenile-Type Metachromatic,Leukodystrophies, Metachromatic,Leukodystrophy, Adult Metachromatic,Leukodystrophy, Adult-Type Metachromatic,Leukodystrophy, Juvenile Metachromatic,Leukodystrophy, Juvenile-Type Metachromatic,Leukoencephalopathies, Metachromatic,Leukoencephalopathy, Metachromatic,Lipidosis, Sulfatide,Metachromatic Leukodystrophies,Metachromatic Leukodystrophies, Adult,Metachromatic Leukodystrophies, Adult-Type,Metachromatic Leukodystrophies, Infant,Metachromatic Leukodystrophies, Infant-Type,Metachromatic Leukodystrophies, Juvenile,Metachromatic Leukodystrophies, Juvenile-Type,Metachromatic Leukodystrophy, Adult Type,Metachromatic Leukodystrophy, Infant Type,Metachromatic Leukodystrophy, Juvenile Type,Metachromatic Leukoencephalopathies,Sulfatase Deficiencies, Cerebroside,Sulfatase Deficiency, Cerebroside
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D002553 Cerebroside-Sulfatase An enzyme that catalyzes the hydrolysis of cerebroside 3-sulfate (sulfatide) to yield a cerebroside and inorganic sulfate. A marked deficiency of arylsulfatase A, which is considered the heat-labile component of cerebroside sulfatase, has been demonstrated in all forms of metachromatic leukodystrophy (LEUKODYSTROPHY, METACHROMATIC). EC 3.1.6.8. Arylsulfatase A,Sulfatidate Sulfatase,Cerebroside Sulfatase,Sulfatase, Sulfatidate
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

Natalia V Olkhovich, and Noboru Takamura, and Natalia A Pichkur, and Natalia G Gorovenko, and Kiyoshi Aoyagi, and Shunichi Yamashita
May 2006, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Natalia V Olkhovich, and Noboru Takamura, and Natalia A Pichkur, and Natalia G Gorovenko, and Kiyoshi Aoyagi, and Shunichi Yamashita
November 2013, Gene,
Natalia V Olkhovich, and Noboru Takamura, and Natalia A Pichkur, and Natalia G Gorovenko, and Kiyoshi Aoyagi, and Shunichi Yamashita
May 2004, Neurochemical research,
Natalia V Olkhovich, and Noboru Takamura, and Natalia A Pichkur, and Natalia G Gorovenko, and Kiyoshi Aoyagi, and Shunichi Yamashita
May 2006, Developmental medicine and child neurology,
Natalia V Olkhovich, and Noboru Takamura, and Natalia A Pichkur, and Natalia G Gorovenko, and Kiyoshi Aoyagi, and Shunichi Yamashita
January 1993, DNA and cell biology,
Natalia V Olkhovich, and Noboru Takamura, and Natalia A Pichkur, and Natalia G Gorovenko, and Kiyoshi Aoyagi, and Shunichi Yamashita
November 2003, Human mutation,
Natalia V Olkhovich, and Noboru Takamura, and Natalia A Pichkur, and Natalia G Gorovenko, and Kiyoshi Aoyagi, and Shunichi Yamashita
November 2019, BMC research notes,
Natalia V Olkhovich, and Noboru Takamura, and Natalia A Pichkur, and Natalia G Gorovenko, and Kiyoshi Aoyagi, and Shunichi Yamashita
February 1969, Archives of neurology,
Natalia V Olkhovich, and Noboru Takamura, and Natalia A Pichkur, and Natalia G Gorovenko, and Kiyoshi Aoyagi, and Shunichi Yamashita
January 2020, BMC research notes,
Natalia V Olkhovich, and Noboru Takamura, and Natalia A Pichkur, and Natalia G Gorovenko, and Kiyoshi Aoyagi, and Shunichi Yamashita
April 1988, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Copied contents to your clipboard!